Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane

Anesthesia and Analgesia

Volumn 104, Issue 3, 2007, Pages 563-568

  Vanacker, Bernard F ^a   Vermeyen, Karel M ^b   Struys, Michel M R F ^c   Rietbergen, Henk ^d   Vandermeersch, Eugene ^a   Saldien, Vera ^b   Kalmar, Alain F ^c   Prins, Martine E ^d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADULT; AGED; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEMALE; HICCUP; HUMAN; HYPOTENSION; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUROMUSCULAR BLOCKING; PARALYSIS; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANDROSTANOLS; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPOFOL; SINGLE-BLIND METHOD; TIME FACTORS; TRACHEA;

EID: 33847190294     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000231829.29177.8e     Document Type: Article

References (21)

1. Bevan DR. Monitoring and reversal of neuromuscular block. Am J Health Syst Pharm. 1999;56(Suppl 1):S10-3.
2. van den Broek L, Proost JH, Wierda JMKH. Early and late reversibility of rocuronium bromide. Eur J Anaesthesiol. 1994;11 (Suppl 9):128-32.
3. Zhang M-Q. Drug-specific cyclodextrins: the future of rapid neuromuscular block reversal? Drugs Future 2003;28:347-54.
4. Adam JM, Bennett J, Bom A, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 2002;45:1806-916.
5. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed 2002;41:265-70.
6. Tarver GJ, Grove SJA, Buchanan K, et al. 2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide. Bioorg Med Chem 2002;10:1819-27.
7. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005;103:695-703.
8. Sorgenfrei I, Larsen PB, Norrild K, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent, sugammadex: a dose-finding and safety study. Anesthesiology 2006;104:667-74.
9. Lowry DW, Mirakhur RK, McCarthy GJ, et al. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998;87:936-40.
10. Wulf H, Ledowski T, Linstedt U, et al. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998;45:526-32.
11. Xue FS, Liao X, Tong SY, et al. Dose-response and time-course of the effect of rocuronium bromide during sevoflurane anaesthesia. Anaesthesia 1998;53:25-30.
12. United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation 12 and Research (CBER). Guidance for industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. October 2005. Available at: www.fda.gov/cder/guidance/ 6922fnl.pdf. Accessed on February 8, 2006.
13. Luo S, Michler K, Johnston P, MacFarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004;37(Suppl):81-90.
14. Suy K, Morias K, Hans P, et al. Fast, effective and safe reversal of rocuronium and vecuronium-induced moderate neuromuscular block by the selective relaxant binding agent Org 25969 [abstract]. Anesthesiology 2005;103:A1119.
15. Kim KS, Cheong MA, Lee HJ, Lee JM. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004;99:1080-5.
16. Suzuki T, Lien CA, Belmont MR, et al. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium. Can J Anaesth 2003;50:879-85.
17. Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001;67:637-40.
18. Yildirim H, Adanir T, Atay A, et al. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol 2004;21:566-70.
19. Kleinsasser A, Loeckinger A, Lindner KH, et al. Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol. Anaesthesia 2001;56:248-50.
20. Saarnivaara L, Klemola UM, Lindgren L, et al. QT interval of the ECG, heart rate and arterial pressure using propofol, methohexital or midazolam for induction of anaesthesia. Acta Anaesthesiol Scand 1990;34:276-81.
21. Saarnivaara L, Hiller A, Oikkonen M. QT interval, heart rate and arterial pressures using propofol, thiopentone or methohexitone for induction of anaesthesia in children. Acta Anaesthesiol Scand 1993;37:419-23.